Hou, Kangcheng https://orcid.org/0000-0001-7110-5596
Ding, Yi
Xu, Ziqi
Wu, Yue
Bhattacharya, Arjun https://orcid.org/0000-0003-1196-4385
Mester, Rachel https://orcid.org/0000-0002-6498-7727
Belbin, Gillian M.
Buyske, Steve https://orcid.org/0000-0001-8539-5416
Conti, David V.
Darst, Burcu F.
Fornage, Myriam https://orcid.org/0000-0003-0677-8158
Gignoux, Chris
Guo, Xiuqing https://orcid.org/0000-0002-5264-5068
Haiman, Christopher
Kenny, Eimear E.
Kim, Michelle
Kooperberg, Charles https://orcid.org/0000-0002-7986-8560
Lange, Leslie
Manichaikul, Ani
North, Kari E. https://orcid.org/0000-0002-8903-0366
Peters, Ulrike https://orcid.org/0000-0001-5666-9318
Rasmussen-Torvik, Laura J.
Rich, Stephen S. https://orcid.org/0000-0003-3872-7793
Rotter, Jerome I.
Wheeler, Heather E. https://orcid.org/0000-0003-1365-9667
Wojcik, Genevieve L. https://orcid.org/0000-0001-7206-8088
Zhou, Ying
Sankararaman, Sriram
Pasaniuc, Bogdan https://orcid.org/0000-0002-0227-2056
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01-CA196569, U01-CA261339)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01-HL151152)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01-HG009120)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01-MH115676)
Article History
Received: 10 August 2022
Accepted: 16 February 2023
First Online: 20 March 2023
Competing interests
: E.E.K. has received personal fees from Regeneron Pharmaceuticals, 23&Me and Illumina, and serves on the advisory boards for Encompass Biosciences, Foresite Labs and Galateo Bio. The remaining authors declare no competing interests.